drugset / Trial / NCT02361619

Dabigatran in an Interaction Probe Drug Cocktail

NCT02361619

Phase 1 Completed 16 enrolled Turku University Hospital
NaSingle-groupOpen-labelBasic science

Summary

Four periods of oral dosing following overnight fasting (1. known metabolic probe drug cocktail consisting of caffeine, diclofenac, esomeprazole, metoprolol, midazolam; 2. dabigatran + cocktail; 3. dabigatran alone; 4. clarithromycin 3 days + cocktail + dabigatran). Blood samples collected for pharmacokinetics over 24 h. Washout between periods. Adverse events, haematology and clinical chemistry recorded.

Timeline

Start
2015-02
Primary completion
2016-09
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule Oral
Subject Clarithromycin Small molecule Oral
Subject Dabigatran Unknown Oral
Subject Diclofenac Other / unclassified Oral
Subject Esomeprazole Small molecule Oral
Subject Metoprolol Other / unclassified Oral
Subject Midazolam Small molecule Oral

Indications

No indication recorded.